Error
America is opening again. Even as more Americans get vaccinated, millions of unvaccinated adults and children are still carrying the virus, new COVID-19 variants threaten our return to normal and possible seasonal surges loom this fall and winter. BinaxNOW is the faster, simpler, more affordable and more accessible innovation in testing that we need to return to life with confidence.
As schools, businesses and our communities move to reopen and stay open, this critical testing technology means institutions and industry can turn the page on long wait times for test results and adopt new simple testing protocols that meet their needs now and move us all forward.
Regular, rapid COVID-19 self-testing – that is simple to do, easy to afford, quick with results – lets us all do more than reopen. We can stay open and stay together.
Abbott is intently monitoring the mutations of COVID-19 so we can ensure our tests can detect them. We have conducted a computational analysis of the new variants, including the Delta variant, and we are confident that our tests remain effective. The Delta variant, along with all other variants of concern, are primarily defined by mutations in the spike protein. Abbott's diagnostic tests do not rely on the spike proteins to detect the virus, which means that these new variants do not affect test performance.
Based on our analysis, the sensitivity and specificity of our tests, including our BinaxNOW rapid antigen tests, are not impacted by the Delta variant. Learn more about Abbott's evaluation of the Delta variant and our commitment to monitoring COVID-19 variants to ensure test effectiveness.
The BinaxNOW COVID-19 Antigen Self Test has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA).
I am interested in tests for our K-12 schools or colleges and universities.
I am interested in testing for business employees.
I am interested in COVID-19 testing for myself or learning more about the test.
Schools are opening again. As we balance smart precautions that help keep students and educators healthy, with the drive to bring classrooms back to life, BinaxNOW Self Test will enable our schools to move forward with confidence. Now, students and educators can learn if they are infectious within 15 minutes, before even going to school, rather than testing and quarantining whole classrooms for days waiting for test results.
By providing testing at greater scale and with greater frequency, rapid COVID-19 self-testing will mean schools don’t just reopen. They can stay open and stay in-person.
Northwestern University, an iconic research university just outside of Chicago, launched a successful university-wide COVID-19 rapid self-testing program for students, faculty, staff and contract employees allowing them to test as frequently as they wanted and know their COVID-19 status before leaving their home. Using BinaxNOW for regular testing has allowed their campus to stay open and in-person.
In a July 2021 survey, 68% of parents see regular testing as a critical component to keep schools open for in-person learning.
Plug & Play
|
Full-service solution
|
|
---|---|---|
Technology |
Utilizes school’s existing tracking platform. Examples of platforms we can support: PowerSchool and Phoenix. |
Utilizes Abbott's NAVICA system – including app and web portal interfaces for individual testing. |
Pre-test user
|
List of pre-defined screening questions and symptom checker for reference. |
Automated text and/or email reminders to complete testing. |
Self test
|
Digital tool kit including: - Step-by-step procedure guide (PDF and videos) |
Digital tool kit including: - Step-by-step procedure guide (PDF and videos) Step by step interactive guidance for conducting tests through NAVICA system. |
Reporting |
Handled by school through existing platform. |
Ability to support CARES/Federal/State reporting. |
Abbott service |
Testing support as needed. |
Full-service support across end-to-end process to mobilize and operate. |
Plug & Play
|
---|
TECHNOLOGYUtilizes school’s existing tracking platform. Examples of platforms we can support: PowerSchool and Phoenix. |
PRE-TEST USER COMMUNICATIONSList of pre-defined screening questions and symptom checker for reference. |
SELF TEST GUIDANCEDigital tool kit including: - Step-by-step procedure guide (PDF and videos) |
REPORTINGHandled by school through existing platform. |
ABBOTT SERVICETesting support as needed. |
Full-service solution
|
---|
TECHNOLOGYUtilizes Abbott's NAVICA system – including app and web portal interfaces for individual testing. |
PRE-TEST USER COMMUNICATIONSAutomated text and/or email reminders to complete testing. |
SELF TEST GUIDANCEDigital tool kit including: - Step-by-step procedure guide (PDF and videos) Step by step interactive guidance for conducting tests through NAVICA system. |
REPORTINGAbility to support CARES/Federal/State reporting. |
ABBOTT SERVICEFull-service support across end-to-end process to mobilize and operate. |
Businesses are opening again. BinaxNOW COVID-19 Antigen Self Test meets the needs of those businesses today and will give employees the confidence to return to in-person work and move forward. Each workplace is different – whether it’s a factory, a small retail storefront, or a large collaborative corporate office – and rapid self-testing with BinaxNOW allows businesses of all types and sizes to customize testing protocol to serve their unique workforce.
Rapid COVID-19 self-testing will mean businesses in every community can do more than open, they can stay open and stay thriving.
Abbott created a BinaxNOW rapid testing protocol and deployed across 40 worksites – from the factory floor to corporate headquarters. That protocol allowed Abbott to stay open since Fall 2020, with less than 1% positivity across all locations.
Read more about Abbott Laboratories’ successful BinaxNOW Pilot Program utilizing the BinaxNOW™ COVID-19 Ag Card.
This video will show you how to use the BinaxNOW COVID-19 Antigen Self Test.
No, when the foam end of the swab is inserted, the nasal swab is not sharp and it should not hurt. Sometimes the swab can feel slightly uncomfortable or tickly. If you feel pain, please stop the test and seek advice from a healthcare provider.
There are different kinds of tests for COVID-19. Molecular tests (also known as PCR tests) detect genetic material from the virus. Antigen tests detect proteins from the virus. Antigen tests are very specific for the virus, but are not as sensitive as molecular tests.
This means that a positive result tends to be accurate, but a negative result does not rule out infection. If your test result is negative, you should discuss with your healthcare provider whether an additional molecular test would help with your care, and when you should discontinue home isolation.
Based on the interim results of a clinical study where the BinaxNOW™ COVID-19 Antigen Self Test was compared to an FDA authorized high sensitivity SARS-CoV-2 test, BinaxNOW COVID-19 Antigen Self Test correctly identified 84.6% of positive specimens and 98.5% of negative specimens.
The BinaxNOW COVID-19 Self Test is identical to the professional-use test, used since August 2020, bringing the most studied and widely used rapid antigen test to retail shelves across the country.
Sensitivity refers to a test's ability to designate an individual with disease as positive.
Specificity of a test is its ability to designate an individual who does not have a disease as negative.
The test is indicated for all people aged 15 years or older and for children as young as two years old when samples are collected by an adult.
The test is available for a low cost, over-the-counter without a prescription and is not currently covered by insurance.
No, this is an antigen test that only detects an active infection. Antibody tests can detect past infections.
No, this is for personal use only and doesn’t provide a documented test result that you can display when traveling. For a documented test result the BinaxNOW COVID-19 Ag Card Home Test may be a better choice. Combined with the NAVICA App and with a negative result, you will have a digital result that may.
Each product box has an expiration date and should not be used after that date.
Yes, you will need a timer/watch and it is recommended that gloves are worn during testing.
COVID-19 Serial testing is when one person tests themselves multiple times for COVID-19 on a routine basis, such as every day or every other day. By testing more frequently, you may detect COVID-19 more quickly and reduce spread of infection.
If your first test is negative, you should test again within 3 days, with at least 36 hours between tests. If your first or second test is positive, then proteins from the virus that causes COVID-19 have been found in your specimen and you likely have COVID-19.
If you test positive with the BinaxNOW COVID-19 Antigen Self Test, you should self-isolate and seek follow-up care with your healthcare provider to determine the next steps you should take. You may need additional testing, depending on your personal health history and other factors.
Abbott is intently monitoring the mutations of COVID so we can ensure our tests can detect them, as we do with many viruses. We have conducted a thorough analysis of known variants that we’ve been able to study, and we are confident that our tests remain effective at identifying these strains.
It is highly likely that future COVID-19 strains will remain detectable because our tests – and most other COVID-19 tests – look for parts of the virus that are crucial for the virus’ survival and therefore less subject to mutation.
The BinaxNOW™ COVID-19 Antigen Self Test has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization. It has been authorized only for the detection of proteins from SARSCoV-2, not for any other viruses or pathogens, and are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. BinaxNOW COVID-19 Antigen Self Test should be performed twice in 3 days, at least 36 hours apart.
Based on your current location, the content on this page may not be relevant for your country.